News - Qiagen, Regulation


Current filters:


Popular Filters

US FDA approves companion diagnostic for Tarceva, and new indication for the Roche drug


The US Food and Drug Administration late yesterday (May 14) approved Swiss drug major Roche (ROG: SIX)…

Boehringer IngelheimNorth AmericaOncologyPharmaceuticalQiagenRegulationRocheTarcevaTomtovok

Boehringer Ingelheim's afatinib NDA gets priority review in USA


The US subsidiary of German independent drug major Boehringer Ingelheim revealed yesterday that the New…

afatinibBoehringer IngelheimNorth AmericaOncologyPharmaceuticalQiagenRegulationTomtovok

US FDA approves Erbitux as first-line treatment in KRAS wild-type EGFR


US drug majors Eli Lilly (NYSE: LLY) and Bristol-Myers Squibb (NYSE: BMY) on Friday received full approval…

Bristol-Myers SquibbEli LillyErbituxNorth AmericaOncologyPharmaceuticalQiagenRegulation

Back to top